Stanford MD · CEO · Longevity Researcher

Hillary Lin, MDLongevity isn't a luxury. It's medicine's unfinished business.

Hillary Lin, MD

As Seen In

We have the science to add decades of healthy life. The gap isn't knowledge — it's access.
Hillary Lin, MD

The Story

From Stanford to the frontier

A physician who left the system to fix it.

2007

Stanford University

Biology and neuroscience. Twelve doctors around the Christmas table growing up. Never questioned whether she'd be one too.

2011

Stanford School of Medicine

MD. Left wanting to treat the whole patient, not just the disease.

2015

Internal Medicine Residency

Board-certified internist. 13 years at Stanford total. The training was excellent. The system was not.

2018

Columbia Hematology/Oncology

Fellowship at Columbia. Saw too many patients arrive too late. Left to build things that could reach people sooner.

2020

Founded Curio

VC-backed psychedelic-assisted therapy platform across 5 states. Built during a pandemic and a personal reinvention.

2024

Aspen Health Fellow

Selected for the Aspen Institute's healthcare leadership program. A family cardiac crisis became a personal turning point toward longevity.

2025

Founded CareCore + The Longevity Show

The company and the media platform. Because longevity medicine shouldn't require a concierge doctor and a $50K annual retainer.

2026

Building

Scaling CareCore, growing the movement. The gap between longevity science and longevity access is closing.

The future of medicine isn't reactive. It's proactive, personalized, and powered by the people brave enough to build it.
Hillary Lin, MD

Stay in the Loop

Two newsletters. One mission.

The Longevity Letter

Weekly longevity science, delivered.

Evidence-based protocols, research breakdowns, and the science of living longer — for patients, curious humans, and people who want to actually do something about their healthspan. Free, every Friday.

Free. No spam. Unsubscribe anytime.

The CareCore Stack

Health-tech intelligence, weekly.

For founders, investors, and builders shaping the longevity economy. Market signals, clinical frontiers, and the business of extending human healthspan — from someone building it.

Free. No spam. Unsubscribe anytime.

Speaking & Advisory

On stage &
in the room.

Longevity science, AI in healthcare, and the future of preventive medicine.

The New Science of Biological Age Reversal
AI-Powered Longevity: From Data to Decades
Why Preventive Medicine is Broken (And How to Fix It)